Stay updated on Ferumoxytol MRI in Glioblastoma Response Clinical Trial

Sign up to get notified when there's something new on the Ferumoxytol MRI in Glioblastoma Response Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ferumoxytol MRI in Glioblastoma Response Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:56:32.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in the study details regarding the sensitivity and specificity of relative cerebral blood volume (rCBV) measured by steady state MRI with ferumoxytol in identifying true versus pseudoprogression in patients with glioblastoma receiving pembrolizumab.
    Difference
    0.1%
    Check dated 2024-06-06T14:24:29.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.' This change provides a more detailed explanation of the eligibility criteria for participation in the study.
    Difference
    47%
    Check dated 2024-05-22T20:55:14.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:51:41.000Z thumbnail image

Stay in the know with updates to Ferumoxytol MRI in Glioblastoma Response Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ferumoxytol MRI in Glioblastoma Response Clinical Trial page.